In the News
Oncode researchers are featured regularly in the media. This shows that their hard work goes beyond the interest of the Oncology community. We are proud of how our Oncode researchers explain their science to the general public. On this page we share the highlights of their media appearances.
October
New Scientific Director
Following the appointment of Jan Paul Medema as new Scientific Director and Head of Oncode Institute, multiple media outlets interviewed him about his vision for Oncode. Articles appeared in Nederlands Tijdschrift voor Oncologie, Oncologie Up-to-date (both hard copy editions) and Medische Oncologie.
Read the article
October
Therapeutic Vaccines platform
Oncode Investigator Sjoerd van der Burg (LUMC) is interviewed by Leidsch Dagblad about the status of cancer vaccines and how this will be developed further within Oncode Accelerator, where he is in the lead of the Therapeutic Vaccines platform.
Read the article Leidsch Dagblad
October
New AI technology
Oncode Investigator Jeroen de Ridder and his lab (UMC Utrecht), together with researchers, pathologists and neurosurgeons from the Princess Máxima Center for pediatric oncology and Amsterdam UMC published in Nature about new AI technology that makes it possible to identify the type of brain tumor a has patient within 1.5 hours. This process normally takes a week. The new technology allows neurosurgeons to adjust their surgical strategies on the spot. This research received an overwhelming amount of national and international attention, including AD, NRC, Medisch Contact and the New York Times.
Read the article in Algemeen Dagblad
Read the article in NRC
Read the article in Medisch Contact
Read the article in New York Times
15 - 07 - 2022
KWF grant for Linde Meyaard
Oncode Investigator Linde Meyaard was one of the lucky scientists to receive a grant from KWF Dutch Cancer Society this summer. NU.nl writes about her aims to research a protein that recognizes collagen, in order to counteract resistance to immunotherapy in cancer.
Read the article on NU.nl
01 - 08 - 2022
Simmunext: an Oncode spinoff
Oncode Invesitagor Emile Voest (Netherlands Cancer Institute) was interviewed on NPO Radio 2 about the DRUP-study. This study investigates whether patients with a certain type of cancer can be successfully helped with a medicine against another type of cancer.
Read the article in Nieuws Nijmegen
24 - 08 - 2022
Boosting the immune system
Oncode Investigator Monika Wolkers provides tips on how to get a stronger immune system in Metronieuws. The article describes the mechanism of action and the benefits of a properly functioning immune system.
Read the article in Metronieuws
05 - 10 - 2022
Developing a smart microscope
Oncode Investigator Miao-Ping Chien has been awarded the Computable Award 2022 in the category Digital Transformation. Computable writes about one of her biggest achievements: developing software and a smart microscope to determine the RNA sequence of single cells that cause metastases.
Read about this on Computable
23 - 08 - 2022
NWO grant mania!
No less than four Oncode Investigators were awarded with XL-grants from the NWO Domain Board Science: Leila Akkari, Tineke Lenstra, Daniël Peeper and Karin Visser. ICT & Health pays attention to the aims of their intended research projects.
Read the article in ICT & Health
06 - 09 - 2022
Wilbert Zwart discusses the progress of his research
Wilbert Zwart was asked to discuss his research for #100uurvoorKWF, where NPO 2 Radio was making 100 hours of radio for KWF to collect money.
September
NPO Radio 2 about the DRUP-study
Oncode Invesitagor Emile Voest (Netherlands Cancer Institute) was interviewed on NPO Radio 2 about the DRUP-study. This study investigates whether patients with a certain type of cancer can be successfully helped with a medicine against another type of cancer.
Listen to Voets' interview here